跳至主要内容
临床试验/EUCTR2015-004133-27-DK
EUCTR2015-004133-27-DK进行中(未招募)1 期

A randomized non-inferiority trial of hypoxia-profile guided hypoxic modification with nimorazole during radiotherapy/chemoradiotherapy of squamous cell carcinoma of the head and neck

Århus Universitetshospital Afd for Eksp. Klinisk onkologi0 个研究点目标入组 1,262 人开始时间: 2016年2月26日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,262

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with HNSCC tumors where, in accordance with DAHANCA’s guidelines, hypoxic modification with nimorazole under primary radiotherapy is indicated.
  • In addition;
  • a)No concurrent or earlier malignant diseases that can affect the treatment, evaluation and outcome of the actual disease
  • b)Informed consent in accordance with regulations
  • c)Radiotherapy planned to start within 3 weeks from inclusion
  • d)Hypoxic status from gene profile testing must be available no later than by the initiation of radiotherapy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 868
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 394

排除标准

  • 未提供

研究者

发起方
Århus Universitetshospital Afd for Eksp. Klinisk onkologi

相似试验